Seer Reports Third Quarter 2023 Financial Results
07 nov. 2023 16h05 HE
|
Seer, Inc.
REDWOOD CITY, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results...
Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program
01 nov. 2023 09h00 HE
|
Seer, Inc.
REDWOOD CITY, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that Panome Bio...
Seer to Report Third Quarter 2023 Financial Results on November 7, 2023
19 oct. 2023 16h05 HE
|
Seer, Inc.
REDWOOD CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that it will...
Seer to Participate in Upcoming September Investor Conferences
08 sept. 2023 16h05 HE
|
Seer, Inc.
REDWOOD CITY, Calif., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced company...
Seer Reports Second Quarter 2023 Financial Results
08 août 2023 16h05 HE
|
Seer, Inc.
REDWOOD CITY, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results...
Seer to Present at the Canaccord Genuity 43rd Annual Growth Conference
27 juil. 2023 16h05 HE
|
Seer, Inc.
REDWOOD CITY, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the...
Seer to Report Second Quarter 2023 Financial Results on August 8, 2023
13 juil. 2023 16h05 HE
|
Seer, Inc.
REDWOOD CITY, Calif., July 13, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it...
Seer Collaborates to Make Scalable, Unbiased Proteomics Accessible to More Researchers via new Seer Technology Access Center
07 juin 2023 09h00 HE
|
Seer, Inc.
REDWOOD CITY, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced an...
Seer Launches the Proteograph XT Assay Kit: Allowing Labs to Easily Expand Their View of the Proteome and Scale Their Studies
01 juin 2023 09h00 HE
|
Seer, Inc.
REDWOOD CITY, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced the launch of the...
Seer Reports First Quarter 2023 Financial Results
09 mai 2023 16h05 HE
|
Seer, Inc.
Grew revenue 22% year-over-year with continued growth in installed base and an increasing number of customer presentations and publications REDWOOD CITY, Calif., May 09, 2023 (GLOBE NEWSWIRE) --...